NexImmune Inc logo

NexImmune Inc

NAS:NEXI (USA)   Ordinary Shares
$ 8.56 +0.78 (+10.03%) 04:00 PM EST
At Loss
P/B:
1.01
Market Cap:
$ 10.24M
Enterprise V:
$ 1.84M
Volume:
464.45K
Avg Vol (2M):
3.38M
Also Trade In:
Volume:
464.45K
At Loss
Avg Vol (2M):
3.38M

Business Description

NexImmune Inc logo
NexImmune Inc
NAICS : 541713 SIC : 2834
ISIN : US65344D2080

Share Class Description:

NEXI: Ordinary Shares
Description
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
Name Current Vs Industry Vs History
Cash-To-Debt 14.88
Equity-to-Asset 0.57
Debt-to-Equity 0.07
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -18
3-Year EPS without NRI Growth Rate -17.8
3-Year FCF Growth Rate -10.9
Name Current Vs Industry Vs History
5-Day RSI 27.49
9-Day RSI 40.01
14-Day RSI 46.05
6-1 Month Momentum % 76.52
12-1 Month Momentum % -32.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.66
Quick Ratio 1.66
Cash Ratio 1.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.4
Shareholder Yield % 4.61
Name Current Vs Industry Vs History
ROE % -170.27
ROA % -129.49
ROIC % -782.26
ROC (Joel Greenblatt) % -885.12
ROCE % -169.71

Financials (Next Earnings Date:2024-03-09 Est.)

NEXI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NEXI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NexImmune Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -42.12
Beta 3.31
Volatility % 589.2
14-Day RSI 46.05
14-Day ATR ($) 2.508499
20-Day SMA ($) 9.2845
12-1 Month Momentum % -32.34
52-Week Range ($) 1.2501 - 28.6949
Shares Outstanding (Mil) 1.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NexImmune Inc Filings

Filing Date Document Date Form
No Filing Data

NexImmune Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NexImmune Inc Frequently Asked Questions

What is NexImmune Inc(NEXI)'s stock price today?
The current price of NEXI is $8.56. The 52 week high of NEXI is $28.69 and 52 week low is $1.25.
When is next earnings date of NexImmune Inc(NEXI)?
The next earnings date of NexImmune Inc(NEXI) is 2024-03-09 Est..
Does NexImmune Inc(NEXI) pay dividends? If so, how much?
NexImmune Inc(NEXI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1